Philip Zeuschner
Overview
Explore the profile of Philip Zeuschner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
213
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pecoraro A, Basile G, Gallioli A, Territo A, Berquin C, Etcheverry B, et al.
Eur Urol Open Sci
. 2024 Mar;
62:16-18.
PMID: 38425835
No abstract available.
12.
Zeuschner P, Friedersdorff F, Siemer S, Stockle M
Urologie
. 2024 Feb;
63(4):361-366.
PMID: 38378943
Background: The first robot-assisted kidney transplantation (RAKT) was conducted in 2010, and the first time in Germany in 2016. As more than 5 years have passed, current evidence, technological developments...
13.
Zeuschner P, Mihm J, Sester U, Stockle M, Friedersdorff F, Budde K, et al.
World J Urol
. 2024 Feb;
42(1):85.
PMID: 38363345
Purpose: The Eurotransplant Senior program allocating grafts from donors ≥ 65 years to recipients aged ≥ 65 years has proven good results within the last 20 years. However, "old" grafts...
14.
Hoeh B, Garcia C, Banek S, Klumper N, Cox A, Ellinger J, et al.
Clin Transl Immunology
. 2023 Oct;
12(10):e1471.
PMID: 37899949
Objectives: Although biomarkers predicting therapy response in first-line metastatic renal carcinoma (mRCC) therapy remain to be defined, C-reactive protein (CRP) kinetics have recently been associated with immunotherapy (IO) response. Here,...
15.
Zeuschner P, Bottcher C, Hager L, Linxweiler J, Stockle M, Siemer S
Cancers (Basel)
. 2023 May;
15(8).
PMID: 37190219
Despite perioperative advantages, robot-assisted surgery is associated with high costs. However, the lower morbidity of robotic surgery could lead to a lower nursing workload and cost savings. In this comparative...
16.
Harke N, Kuczyk M, Huusmann S, Schiefelbein F, Schneller A, Schoen G, et al.
Eur Urol Open Sci
. 2022 Dec;
46:45-52.
PMID: 36506259
Background: Robot-assisted partial nephrectomy (RAPN) is a challenging procedure that is influenced by a multitude of factors. Objective: To assess the impact of prior surgical experience on perioperative outcomes in...
17.
Zeuschner P, Junker K
Eur Urol Focus
. 2022 Aug;
8(4):907-909.
PMID: 35918269
Despite the recent approval of numerous immune checkpoint inhibitors (ICIs) for the treatment of genitourinary tumors, predictive biomarkers are still lacking. Different approaches are necessary, as the only approved biomarker...
18.
Klumper N, Sikic D, Saal J, Buttner T, Goldschmidt F, Jarczyk J, et al.
Eur J Cancer
. 2022 Apr;
167:13-22.
PMID: 35366569
Purpose: Robust biomarkers to predict response to immune checkpoint blockade (ICB) in metastatic urothelial carcinoma (mUC) are still in demand. Recently, early C-reactive protein (CRP) kinetics and especially the novel...
19.
Linxweiler J, Hajili T, Zeuschner P, Menger M, Stockle M, Junker K, et al.
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35159004
Radical prostatectomy in oligometastatic prostate cancer is a matter of intense debate. Besides avoiding local complications, it is hypothesized that primary tumor resection may result in better oncological outcomes. The...
20.
Hoeh B, Schmucker P, Klumper N, Hahn O, Zeuschner P, Banek S, et al.
Urol Int
. 2022 Feb;
106(11):1150-1157.
PMID: 35158357
Introduction: The aim of this study was to test for differences in overall (OS) and progression-free survival (PFS) rates and toxicity in first-line immune checkpoint inhibition (IO) combination therapy in...